{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:43Z","timestamp":1777984303712,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12918-2","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:52:17Z","timestamp":1772445137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Descriptive analysis of frequency and antimicrobial susceptibility of pathogens isolated from acute leukemia patients with febrile neutropenia over a four-year period at a tertiary hospital"],"prefix":"10.1186","volume":"26","author":[{"given":"Adan","family":"Iftekhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afia","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Zeeshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra","family":"Fadoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammarah","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Sadiqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Shayan","family":"Ashfaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"12918_CR1","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.lanepe.2025.101214","volume":"51","author":"M Sandherr","year":"2025","unstructured":"Sandherr M, Stemler J, Schalk E, Hattenhauer T, Hentrich M, Hertenstein B, et al. 2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies. Lancet Reg Health - Europe. 2025;51:101214.","journal-title":"Lancet Reg Health - Europe"},{"issue":"8","key":"12918_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/oncolo\/oyac074","volume":"27","author":"R Boccia","year":"2022","unstructured":"Boccia R, Glaspy J, Crawford J, Aapro M. Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed? Oncologist. 2022;27(8):625\u201336.","journal-title":"Oncologist"},{"issue":"1","key":"12918_CR3","doi-asserted-by":"publisher","first-page":"e2020009","DOI":"10.4084\/mjhid.2020.009","volume":"12","author":"BA Hansen","year":"2020","unstructured":"Hansen BA, Wendelbo \u00d8, Bruserud \u00d8, Hemsing AL, Mosevoll KA, Reikvam H. Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment. Mediterr J Hematol Infect Dis. 2020;12(1):e2020009.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"12918_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-662-44000-1_1","volume-title":"Infections in Hematology","author":"KVI Rolston","year":"2015","unstructured":"Rolston KVI. Infections in Patients with Acute Leukemia. Infections in Hematology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. pp. 3\u201323."},{"issue":"14","key":"12918_CR5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018;36(14):1443\u201353.","journal-title":"J Clin Oncol"},{"key":"12918_CR6","doi-asserted-by":"crossref","unstructured":"Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence\u2014implications for human health and treatment perspectives. EMBO Rep. 2020;21(12).","DOI":"10.15252\/embr.202051034"},{"issue":"5","key":"12918_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1586\/17474086.2015.1071186","volume":"8","author":"MA Caniza","year":"2015","unstructured":"Caniza MA, Odio C, Mukkada S, Gonzalez M, Ceppi F, Chaisavaneeyakorn S, et al. Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries. Expert Rev Hematol. 2015;8(5):627\u201345.","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"12918_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF01695660","volume":"15","author":"E Gonz\u00e1lez-Barca","year":"1996","unstructured":"Gonz\u00e1lez-Barca E, Fern\u00e1ndez-Sevilla A, Carratal\u00e1 J, Gra\u00f1ena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis. 1996;15(4):291\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"12918_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States. Clin Infect Dis. 2003;36(9):1103\u201310.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"12918_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","volume":"68","author":"M Mikulska","year":"2014","unstructured":"Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2014;68(4):321\u201331.","journal-title":"J Infect"},{"issue":"6","key":"12918_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/tid.12298","volume":"16","author":"N Macesic","year":"2014","unstructured":"Macesic N, Morrissey CO, Cheng AC, Spencer A, Peleg AY. Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period. Transpl Infect Dis. 2014;16(6):887\u201396.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"12918_CR12","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1017\/S0950268809991208","volume":"138","author":"CY Chen","year":"2010","unstructured":"Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, et al. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect. 2010;138(7):1044\u201351.","journal-title":"Epidemiol Infect"},{"issue":"8","key":"12918_CR13","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","volume":"91","author":"C Cattaneo","year":"2012","unstructured":"Cattaneo C, Antoniazzi F, Casari S, Ravizzola G, Gelmi M, Pagani C, et al. P. aeruginosa bloodstream infections among hematological patients: an old or new question? Ann Hematol. 2012;91(8):1299\u2013304.","journal-title":"Ann Hematol"},{"issue":"7","key":"12918_CR14","first-page":"439","volume":"110","author":"P Sood","year":"2012","unstructured":"Sood P, Seth T, Kapil A, Sharma V, Dayama A, Sharma S, et al. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes. J Indian Med Assoc. 2012;110(7):439\u201344.","journal-title":"J Indian Med Assoc"},{"issue":"2","key":"12918_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","volume":"27","author":"EM Trecarichi","year":"2014","unstructured":"Trecarichi EM, Tumbarello M. Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer. Curr Opin Infect Dis. 2014;27(2):200\u201310.","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"12918_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","volume":"18","author":"R Cant\u00f3n","year":"2012","unstructured":"Cant\u00f3n R, Ak\u00f3va M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"12918_CR17","doi-asserted-by":"crossref","unstructured":"Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015;20(45).","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062"},{"issue":"2","key":"12918_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/jac\/dkp411","volume":"65","author":"C Gudiol","year":"2010","unstructured":"Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, et al. Bacteraemia due to extended-spectrum -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother. 2010;65(2):333\u201341.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"12918_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbmt.2008.10.024","volume":"15","author":"M Mikulska","year":"2009","unstructured":"Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transpl. 2009;15(1):47\u201353.","journal-title":"Biol Blood Marrow Transpl"},{"key":"12918_CR20","unstructured":"Karim M, Khan W, Farooqi B, Malik I. Bacterial isolates in neutropenic febrile patients. J Pak Med Assoc. 1991;41(2). Available at: https:\/\/ecommons.aku.edu\/pakistan_fhs_mc_med_intern_med\/47."},{"key":"12918_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.amsu.2018.09.004","volume":"34","author":"B Siddiqui","year":"2018","unstructured":"Siddiqui B, Azmat R, Tikmani SS, Rafi S, Syed B, Khan MT, et al. Frequency of bloodstream infection in febrile neutropenic patients, experience from a developing country. Annals Med Surg. 2018;34:71\u20134.","journal-title":"Annals Med Surg"},{"issue":"6","key":"12918_CR22","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.12669\/pjms.36.6.2138","volume":"36","author":"U Mahar","year":"2020","unstructured":"Mahar U, Anwar N, Fatima N, Hassan J, Shamsi T. Emerging Anti-Microbial Resistance in Febrile Neutropenia: Is it high time to evaluate quality control measures? Pak J Med Sci. 2020;36(6):1246\u201351.","journal-title":"Pak J Med Sci"},{"issue":"4","key":"12918_CR23","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56\u201393.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"12918_CR24","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"12918_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"12918_CR26","unstructured":"James S, Lewis II, Melvin P, Weinstein AM, Bobenchik. Shelley Campeau. M100 performance standards for antimicrobial susceptibility testing A CLSI supplement for global application. 32nd Ed. [Internet]. 2022. Available from: www.clsi.org."},{"key":"12918_CR27","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Data from the EUCAST MIC distribution website [Internet]. 2023;[cited 2026 Jan 11]. Available from: https:\/\/www.eucast.org\/."},{"key":"12918_CR28","unstructured":"Gary W, Procop, Philippe J, Dufresne. Elizabeth Berkow. Performance standards for antifungal susceptibility testing of yeasts. 2022 Aug 3 [cited 2026 Jan 11]; Available from: https:\/\/clsi.org\/shop\/standards\/m27m44s\/."},{"key":"12918_CR29","unstructured":"Procop G, Dufresne P, Berkow E, Cullen S. Jeff Fuller. Clinical and Laboratory Standards Institute. Epidemiological cutoff values for antifungal susceptibility testing; 2022."},{"issue":"11","key":"12918_CR30","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.cmi.2020.06.007","volume":"26","author":"MC Arendrup","year":"2020","unstructured":"Arendrup MC, Friberg N, Mares M, Kahlmeter G, Meletiadis J, Guinea J, et al. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2020;26(11):1464\u201372.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"12918_CR31","doi-asserted-by":"publisher","first-page":"106919","DOI":"10.1016\/j.ijantimicag.2023.106919","volume":"62","author":"H Erdem","year":"2023","unstructured":"Erdem H, Kocoglu E, Ankarali H, El-Sokkary R, Hakamifard A, Karaali R, et al. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study. Int J Antimicrob Agents. 2023;62(3):106919.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"12918_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.32641\/andespediatr.v93i1.3629","volume":"93","author":"AK Bello-Su\u00e1rez","year":"2022","unstructured":"Bello-Su\u00e1rez AK, Cuesta-Armesto MH, D\u00edaz-Rojas MJ, Mendoza-Uribe L, Sarmiento-Wilches PE. Microbiological characterization and antimicrobial susceptibility pattern of infections associated with febrile neutropenia in pediatric hemato-oncological patients. Andes pediatrica: revista Chil de pediatria. 2022;93(1):65\u201377.","journal-title":"Andes pediatrica: revista Chil de pediatria"},{"key":"12918_CR33","doi-asserted-by":"crossref","unstructured":"Zimmer AJ, Stohs E, Meza J, Arnold C, Baddley JW, Chandrasekar P, et al. Bloodstream infections in hematologic malignancy patients with fever and neutropenia: are empirical antibiotic therapies in the United States still effective? Open Forum Infect Dis. 2022;9(7).","DOI":"10.1093\/ofid\/ofac240"},{"issue":"7","key":"12918_CR34","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/cid\/ciab404","volume":"73","author":"MJ Satlin","year":"2021","unstructured":"Satlin MJ, Chen L, Douglass C, Hovan M, Davidson E, Soave R, et al. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients. Clin Infect Dis. 2021;73(7):1257\u201365.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"12918_CR35","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1186\/s12879-025-12026-7","volume":"25","author":"R Moghnieh","year":"2025","unstructured":"Moghnieh R, Khalil A, Khoury A, Abdessamad H, Sfeir P, Mezher M, et al. The impact of fluoroquinolone-resistant enterobacterales colonization on fluoroquinolone prophylaxis efficacy in hematopoietic cell transplant recipients. BMC Infect Dis. 2025;25(1):1582.","journal-title":"BMC Infect Dis"},{"key":"12918_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2334-8-80","volume":"8","author":"S Irfan","year":"2008","unstructured":"Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis. 2008;8:80.","journal-title":"BMC Infect Dis"},{"key":"12918_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jgar.2024.03.018","volume":"37","author":"F Yuan","year":"2024","unstructured":"Yuan F, Li M, Wang X, Fu Y. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study. J Glob Antimicrob Resist. 2024;37:150\u20136.","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"12918_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3947\/ic.2016.48.3.181","volume":"48","author":"JH Lee","year":"2016","unstructured":"Lee JH, Kim SK, Kim SK, Han SB, Lee JW, Lee DG, et al. Increase in Antibiotic-Resistant Gram-Negative Bacterial Infections in Febrile Neutropenic Children. Infect Chemother. 2016;48(3):181\u20139.","journal-title":"Infect Chemother"},{"issue":"14","key":"12918_CR39","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.3390\/jcm14144928","volume":"14","author":"E Truszkowska","year":"2025","unstructured":"Truszkowska E, Czy\u017cewski K, Derwich K, Jaremek K, Grochowska O, Zalas-Wi\u0119cek P, et al. Clinical Analysis of Acinetobacter Species Infections in Children and Adolescents Treated for Cancer or Undergoing Hematopoietic Cell Transplantation: A Multicenter Nationwide Study. J Clin Med. 2025;14(14):4928.","journal-title":"J Clin Med"},{"issue":"2","key":"12918_CR40","first-page":"161","volume":"10","author":"S Ganguly Bhattacharjee","year":"2024","unstructured":"Ganguly Bhattacharjee S, Mandal S, Mullick SS, Bhunia S, Kundu S, Banik A, et al. Microbiological profile and antimicrobial susceptibility patterns of blood stream infections in febrile neutropenic patients with hematological malignancies in a tertiary care hospital, Kolkata. IP Int J Med Microbiol Trop Dis. 2024;10(2):161\u20138.","journal-title":"IP Int J Med Microbiol Trop Dis"},{"issue":"3","key":"12918_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.12692\/ijb\/10.3.24-34","volume":"10","author":"M Khattak","year":"2017","unstructured":"Khattak M, Nawaz S, Muhammad Neak, Jamal A, Akhtar S, Kamran R, et al. Prevalence of vancomycin-resistant enterococci from three tertiary care hospitals and role of esp gene in biofilm formation. Int J Biosci (IJB). 2017;10(3):24\u201334.","journal-title":"Int J Biosci (IJB)"},{"key":"12918_CR42","unstructured":"Commission on Safety A. in Health Care Q. AURA 2019: Third Australian report on antimicrobial use and resistance in human health [Internet]. 2019 [cited 2025 Dec 28]. Available from: https:\/\/www.safetyandquality.gov.au\/https:\/\/www.safetyandquality.gov.au\/antimicrobial-use-and-resistance-in-australia\/."},{"key":"12918_CR43","doi-asserted-by":"crossref","unstructured":"Mendes RE, Castanheira M, Farrell DJ, Flamm RK, Sader HS, Jones RN. Longitudinal (2001\u201314) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010\u201313) analysis of oritavancin in vitro potency. J Antimicrob Chemother. 2016;71(12):3453\u20138.","DOI":"10.1093\/jac\/dkw319"},{"issue":"8","key":"12918_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/apm.13336","volume":"131","author":"P Jangir","year":"2023","unstructured":"Jangir P, Kalra S, Tanwar S, Bari VK. Azole resistance in in Candida auris: mechanisms and combinatorial therapy. APMIS. 2023;131(8):442\u201362.","journal-title":"APMIS"},{"key":"12918_CR45","doi-asserted-by":"crossref","unstructured":"Arastehfar A, Daneshnia F, Hilmio\u011flu-Polat S, Fang W, Ya\u015far M, Polat F, et al. First report of candidemia clonal outbreak caused by emerging fluconazole-resistant candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey. Antimicrob Agents Chemother. 2020;64(10).","DOI":"10.1128\/AAC.01001-20"},{"issue":"5","key":"12918_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s15010-010-0044-x","volume":"38","author":"B Behera","year":"2010","unstructured":"Behera B, Singh RI, Xess I, Mathur P, Hasan F, Misra MC. Candida rugosa: a possible emerging cause of candidaemia in trauma patients. Infection. 2010;38(5):387\u201393.","journal-title":"Infection"},{"issue":"2","key":"12918_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12088-019-00789-y","volume":"59","author":"A Jamal","year":"2019","unstructured":"Jamal A, Fatima N, Shaikh S, Kaleem B, Rizvi QA, Zaidi U, et al. Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study. Indian J Microbiol. 2019;59(2):188\u201392.","journal-title":"Indian J Microbiol"},{"issue":"10","key":"12918_CR48","first-page":"2741","volume":"18","author":"AH Osmani","year":"2017","unstructured":"Osmani AH, Jabbar AA, Gangwani MK, Hassan B. Outcomes of High Risk Patients with Febrile Neutropenia at a Tertiary Care Center. Asian Pac J Cancer Prev. 2017;18(10):2741\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"12918_CR49","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmi.2019.07.002","volume":"26","author":"D Viasus","year":"2020","unstructured":"Viasus D, Puerta-Alcalde P, Cardozo C, Su\u00e1rez-Lled\u00f3 M, Rodr\u00edguez-N\u00fa\u00f1ez O, Morata L, et al. Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection. Clin Microbiol Infect. 2020;26(3):345\u201350.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"12918_CR50","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.31557\/APJCP.2019.20.5.1471","volume":"20","author":"HA Vahedian-Ardakani","year":"2019","unstructured":"Vahedian-Ardakani HA, Moghimi M, Shayestehpour M, Doosti M, Amid N. Bacterial Spectrum and Antimicrobial Resistance Pattern in Cancer Patients with Febrile Neutropenia. Asian Pac J Cancer Prev. 2019;20(5):1471\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"12918_CR51","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1155\/2014\/702621","volume":"25","author":"RG Rosa","year":"2014","unstructured":"Rosa RG, Dos Santos RP, Goldani LZ. Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: A cohort study. Can J Infect Dis Med Microbiol. 2014;25(1):e14\u20137.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"12918_CR52","doi-asserted-by":"crossref","unstructured":"Gautam S, Das S, Singh PK, Rai G, Jain C, Saha R, et al. Predictors of Candidemia during Febrile Episode in Lymphoreticular Malignancy Affecting Paediatric Population. Diagnostics (Basel). 2023;13(9).","DOI":"10.3390\/diagnostics13091638"},{"issue":"1","key":"12918_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13756-020-00731-8","volume":"9","author":"S Moin","year":"2020","unstructured":"Moin S, Farooqi J, Jabeen K, Laiq S, Zafar A. Screening for triazole resistance in clinically significant Aspergillus species; report from Pakistan. Antimicrob Resist Infect Control. 2020;9(1):62.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12918_CR54","doi-asserted-by":"crossref","unstructured":"Ghahri M, Mirhendi H, Zomorodian K, Kondori N. Identification and antifungal susceptibility patterns of candida strains isolated from blood specimens in Iran. Arch Clin Infect Dis. 2013;8(3).","DOI":"10.5812\/archcid.14529"},{"issue":"4","key":"12918_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/jhin.2001.1151","volume":"50","author":"V Krcmery","year":"2002","unstructured":"Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50(4):243\u201360.","journal-title":"J Hosp Infect"},{"key":"12918_CR56","doi-asserted-by":"publisher","first-page":"107183","DOI":"10.1016\/j.ijid.2024.107183","volume":"147","author":"M Chumbita","year":"2024","unstructured":"Chumbita M, Peyrony O, Teij\u00f3n-Lumbreras C, Monz\u00f3-Gallo P, Aiello TF, Gallardo-Pizarro A, et al. Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies. Int J Infect Dis. 2024;147:107183.","journal-title":"Int J Infect Dis"},{"issue":"19","key":"12918_CR57","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1021\/acs.jpca.4c08800","volume":"129","author":"NM Ariyasingha","year":"2025","unstructured":"Ariyasingha NM, Oladun C, Samoilenko A, Chowdhury MRH, Nantogma S, Shi Z, et al. Parahydrogen-Hyperpolarized Propane-Gas Contrast Agent: Relaxation Dynamics and Pilot Millimeter-Scale Ventilation MRI. J Phys Chem A. 2025;129(19):4275\u201387.","journal-title":"J Phys Chem A"},{"issue":"24","key":"12918_CR58","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1039\/D4AN01029A","volume":"149","author":"MRH Chowdhury","year":"2024","unstructured":"Chowdhury MRH, Oladun C, Ariyasingha NM, Samoilenko A, Bawardi T, Burueva DB, et al. Rapid lung ventilation MRI using parahydrogen-induced polarization of propane gas. Analyst. 2024;149(24):5832\u201342.","journal-title":"Analyst"},{"issue":"10","key":"12918_CR59","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1021\/cbmi.4c00041","volume":"2","author":"NM Ariyasingha","year":"2024","unstructured":"Ariyasingha NM, Samoilenko A, Chowdhury MRH, Nantogma S, Oladun C, Birchall JR, et al. Developing Hyperpolarized Butane Gas for Ventilation Lung Imaging. Chem biomedical imaging. 2024;2(10):698\u2013710.","journal-title":"Chem biomedical imaging"},{"issue":"2","key":"12918_CR60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1053\/j.semnuclmed.2017.11.003","volume":"48","author":"AA Ordonez","year":"2018","unstructured":"Ordonez AA, Jain SK. Pathogen-Specific Bacterial Imaging in Nuclear Medicine. Semin Nucl Med. 2018;48(2):182\u201394.","journal-title":"Semin Nucl Med"},{"issue":"10","key":"12918_CR61","doi-asserted-by":"publisher","first-page":"e108969","DOI":"10.1371\/journal.pone.0108969","volume":"9","author":"RG Rosa","year":"2014","unstructured":"Rosa RG, Goldani LZ. Factors associated with hospital length of stay among cancer patients with febrile neutropenia. PLoS ONE. 2014;9(10):e108969.","journal-title":"PLoS ONE"},{"issue":"3","key":"12918_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s40487-025-00356-0","volume":"13","author":"SA Wondm","year":"2025","unstructured":"Wondm SA, Tarekegn GY, Dagnew FN, Dagnew SB, Moges TA, Zeleke TK, et al. Clinical Outcome of Febrile Neutropenia and Associated Factors Among Adult Patients with Cancer Treated at Ethiopian Oncology Centers: A Retrospective Observational Study. Oncol Ther. 2025;13(3):711\u201334.","journal-title":"Oncol Ther"},{"issue":"3","key":"12918_CR63","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/mco.2015.524","volume":"3","author":"J DE Castro Carpe\u00f1o","year":"2015","unstructured":"DE Castro Carpe\u00f1o J, Gasc\u00f3n-Vilaplana P, Tejerina AMCFD, Ant\u00f3n-Torres A, L\u00f3pez-L\u00f3pez R, Barnadas-Molins A, et al. Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study. Mol Clin Oncol. 2015;3(3):725\u20139.","journal-title":"Mol Clin Oncol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12918-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:03:22Z","timestamp":1775574202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12918"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12918-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8193956\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was reviewed and approved as an exemption by the Ethics Review Committee, Aga Khan University. The case number is: 2023-8609-24894. The study is conducted as per protocol, in accordance with all Aga Khan University standards. The research conducted is in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The data were entirely unidentifiable, hence no consent for publication was needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"730"}}